Private Equity
Runnable has secured $2 million in seed funding. Sierra Ventures led the round with participation from Resolute.VC, Angel Pad and 500 Startups. Other investors include Hiten Shah, founder of KISSmetrics and LinkedIn advisor, and Issac Roth, founder of Makara and StrongLoop. Based in Palo Alto, Calif., Runnable is a platform for finding reusable code.
2 min read · 30 October 2013
PathoGenetix has raised $10 million in Series C financing. Return backers Ascension Health Ventures, Excel Venture Management and HealthCare Ventures participated in the round. Based in Woburn, Mass., PathoGenetix is a provider of rapid bacterial identification solutions.
4 min read · 30 October 2013
New York-based Jibe said Wednesday that it has received a $4 million credit facility from Silicon Valley Bank. Backed by Longworth Venture Partners, Polaris Partners, Draper Fisher Jurveston and Gotham Ventures, Jibe is a provider of software solutions for human resources.
3 min read · 30 October 2013
Revenew said Wednesday that it has raised $5 million in Series B financing. Allos Ventures led the round with participation from TGap Ventures and Illinois Ventures. Revenew is a marketing network provider.
6 min read · 30 October 2013
Adaptive Planning said Wednesday that Salesforce.com and other private and corporate investors have joined its latest $45 million funding round. Also, new investor Jeff Epstein, an operating partner at Bessemer Venture Partners, has been named as a senior advisor to the company. Headquartered in Palo Alto, Calif., Adaptive Planning is a provider of cloud-based business and financial analytics solutions for companies and nonprofits. It is backed by Bessemer Venture Partners, Norwest Venture Partners, Royal Bank of Canada, ONSET Ventures, Monitor Ventures and Cardinal Venture Capital.
4 min read · 30 October 2013
Harvest Automation has raised $11.75 million in Series C financing. New York-based Mousse Partners Limited led the round with participation from existing investors Life Sciences Partners, Cultivian, Founder Collective, Entrée Capital and MassVentures. Also, Ed Zysik, vice president at Mousse Partners Limited, will join Harvest Automation's board of directors. Based in Billerica, Mass., Harvest Automation is a provider of robotic solutions for the agriculture market.
2 min read · 30 October 2013
PneumaCare said Wednesday that it has raised £1 million in financing. Investors included Sud Investments, Torteval and business angels from Cambridge Capital Group and Cambridge Angels. Also, the company has named Edward Benthall to its board of directors. Benthall is currently chairman of Cambridge Enterprise and the recently launched Cambridge Innovation Capital Fund. Based in Cambridge, UK, PneumaCare is a provider of respiratory diagnostic and monitoring equipment using 3D-imaging technology.
2 min read · 30 October 2013
Securus Medical Group has raised $6.5 million in Series B financing. New investor 3X5 Special Opportunity Fund led the round with participation from RiverVest Venture Partners and the University of Michigan Investment in New Technology Startups program. In addition to the funding, the company has named Dr. Steven Girouard as president and CEO. Also, Nicholas Walrod, a principal at 3X5 Special Opportunity Fund, joins the company's board of directors. Based in Cleveland, Securus is a medical device company.
2 min read · 29 October 2013
Illumina has agreed to acquire NextBio. No financial terms were disclosed for the transaction, which is expected to close by the end of October. Based in Cupertino, Calif., NextBio, which is backed by Newbury Ventures, is a provider of clinical and genomic informatics.
3 min read · 29 October 2013
Calithera Biosciences said Tuesday that it has closed $35 million in Series D financing. Adage Capital Partners led the round with participation from the Longwood Fund, Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures. Also, Dr. Christoph Westphal, partner and co-founder of the Longwood Fund, joins Calithera's board of directors as an observer. Based in South San Francisco, Calif., Calithera Biosciences is a biotech company that develops cancer therapeutics.
3 min read · 29 October 2013
